Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. Surgical's Ray TFC

This article was originally published in The Gray Sheet

Executive Summary

Tyco subsidiary and its Surgical Dynamics unit settle two outstanding patent infringement disputes related to sales of the Ray threaded spinal fusion implant and methods and instruments by which the devices are implanted. The settlement, which includes one-time payment and royalty-bearing agreements, resolves disputes with competitors Medtronic Sofamor Danek and Sulzer Spine-Tech, as well as Karlin Technology. In a California federal court suit, the Ray was found to infringe U.S. technology patent 5,015,247 owned by Karlin Technology. A Tennessee federal court suit found the Ray insertion method also infringes U.S. method patent 5,741,253, which was issued to Gary Karlin Michelson, founder of Karlin Technology, and is now owned by Medtronic. Existing agreements relating to the patents cover Medtronic's InterFix and InterFix RP spinal fusion cages, and Sulzer Spine-Tech's BAK and BAK Proximity spinal fusion cages

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014394

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel